WHC is still in active development. Read this to understand our approach.
depiction of KORNTPPJEAJQIU-UHFFFAOYSA-N.svg
psychonaut

Cabergoline

Check on psychonaut

isomerdesign

N-[3-(Dimethylamino)...

Check on isomerdesign

drugmap

Cabergoline

Check on drugmap

wiki

Cabergoline

Check on wiki

Data

InChI: InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)

Synonyms: FCE-21336FCE-21336,Dostinex (TN),DSSTox_RID_76698,BRD-K86882815-001-01-6,1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea,CABERGOLINE [MI],MFCD00867887,GTPL37,Cabaseril,(9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide, Galastop,CABERGOLINE [USP-RS], Sogilen,Cabergoline, >=98% (HPLC),HY-15296, Cabergolinum,(8β)-N-[3-(Dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide,UNII-LL60K9J05T,Cabaser (TN),Dostinex,Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)-,AB01275484-01,Cabergoline (JAN/USP/INN),DTXSID6022719, Cabergolina [Spanish],SR-05000001493-2,CABERGOLINE [EP MONOGRAPH],FCE 21336,CHEBI:3286,CABERGOLINE [USAN],Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-,Cabergolinum [Latin],cabergoline,1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea,CABERGOLINE [INN],CABERGOLINE [EMA EPAR VETERINARY],Velactis,1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea,BIDD:GT0775,Cabaser,Cabergolina [Spanish],6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide,Q423308, (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide,CABERGOLINE [ORANGE BOOK],(8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide,ZINC3800008, Cabergoline (JAN/USAN/INN), Dostinex,Sogilen,BRN 6020775,CHEMBL1201087, Cabaser (TN),1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea,s5842,BDBM50426497,SCHEMBL42292,Cabergoline, European Pharmacopoeia (EP) Reference Standard,(8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide,D00987, CG-101, 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate, (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide, 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea,1-((6-ALLYLERGOLIN-8.BETA.-YL)CARBONYL)-1-(3-(DIMETHYLAMINO)PROPYL)-3-ETHYLUREA, 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea,SR-05000001493,CABERGOLINE [VANDF],409C907,CAS-81409-90-7,N-[3-(Dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8β-carboxamide,HMS3886H05,Cabergoline [USAN:USP:INN:BAN],Caberlin, Cabergolinum [Latin],NCGC00167821-01, (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide,CABERGOLINE [MART.],(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide,(6aR,9R,10aR)-N-[3-(Dimethylamino)propyl]-N-(ethylcarbamoyl)-7-(prop-2-en-1-yl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide, 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea,DSSTox_GSID_22719,Cabergolina,ERGOLINE-8.BETA.-CARBOXAMIDE, N-(3-(DIMETHYLAMINO)PROPYL)-N-((ETHYLAMINO)CARBONYL)-6-(2-PROPENYL)-,AKOS015961587,CABERGOLINE [WHO-DD],CG-101,Tox21_112589,ETHYL4-METHYL-2-PYRIDIN-3-YL-1,3-THIAZOLE-5-CARBOXYLATE,LL60K9J05T,CABERGOLINE [JAN],AC-26126, Cabaseril,FCE-21336,DB00248,C08187,Cabergoline, United States Pharmacopeia (USP) Reference Standard,F17353,SR-05000001493-1, FCE-21336, (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide,81409-90-7, Cabergoline [USAN:BAN:INN], Cabergolina,CABERGOLINE [USP MONOGRAPH],DSSTox_CID_2719, Dostinex (TN),(8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide,(6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide,HMS2090A09,N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide,NCGC00344544-01,Tox21_112589_1,Cabergolinum,(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide

Estimated data

Solubility: -3.234 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 45.6% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.